• Arthur J. Gallagher & Co.: TD Cowen downgrades to hold from market perform with a price target raised from USD 249 to USD 273.
  • BROWN-FORMAN -A: Citi downgrades to neutral from sell with a target price of USD 52.
  • BROWN-FORMAN -B: Citi downgrades to neutral from sell with a target price of USD 52.
  • Eaton Corporation Plc: Barclays upgrades to equalweight from underweight with a price target raised from USD 250 to USD 300.
  • Estee Lauder: Citi upgrades to buy from neutral with a price target raised from USD 160 to USD 175.
  • Fifth Third Bancorp: Baird downgrades to neutral from outperform with a target price of USD 32.
  • Humana Inc.: TD Cowen upgrades to buy from outperform with a price target reduced from USD 427 to USD 396.
  • Moody's Corporation: Barclays upgrades to overweight from equalweight with a price target raised from USD 375 to USD 450.
  • The Clorox Company: Citi downgrades to neutral from buy with a price target reduced from USD 170 to USD 165.
  • Willis Towers Watson Public Limited Company: TD Cowen upgrades to buy from outperform with a price target raised from USD 316 to USD 329.
  • Eli Lilly And Company: Citigroup maintains its buy recommendation with a price target raised from USD 675 to USD 895.
  • Convatec Group Plc: HSBC upgrades to buy from hold with a price target raised from GBP 2.20 to GBP 3.50.
  • Zebra Technologies Corporation: Barclays initiates an Equalweight recommendation with a target price of USD 292.
  • Ppg Industries, Inc.: Bernstein initiates an Outperform recommendation with a target price of USD 166.
  • National Grid PL: BNP Paribas Exane upgrades to outperform from underperform with a price target raised from GBX 950 to GBX 1250.
  • Bce Inc.: BMO Capital Markets downgrades to market perform from outperform with a price target reduced from CAD 54 to CAD 46.